Peplin investor MPM BioVentures ups equity stake to 23.1%

By Angela McDaniels

Tacoma, Wash., Jan. 23 - Peplin, Inc. investors led by MPM BioVentures IV Q-P, LP purchased Chess Depositary Interests representing 20,308 shares of the company's common stock between Jan. 13 and Jan. 22, according to a schedule 13D filed with the Securities and Exchange Commission.

Each Chess Depositary Interest represents 20 shares. The equivalent price per share ranged from $7.03 to $8.40.

Following the purchases, the investors beneficially own 3,679,328 shares, or 23.1%, of the company.

Peplin is a specialty pharmaceutical company based in Emeryville, Calif., that develops medical dermatology products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.